miércoles, 26 de agosto de 2026
World's Largest Generic Drugmaker Faces Antitrust Investigation
World's Largest Generic Drugmaker Faces Antitrust Investigation
Turkish antitrust authorities this month launched the probe into whether Teva Pharmaceuticals manipulated the patent system to squash competition, Stat reported. Teva has denied any wrongdoing and agreed to cooperate with investigators.
https://kffhealthnews.org/morning-breakout/pharma-and-tech-082626/
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario